#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bulbospinal muscular atrophy congenital Richter's syndrome Neurofibroma Demyelination Bronchiolitis Haemophilia A without inhibitors Diabetes insipidus Niemann-Pick disease Mastocytosis Retinopathy of prematurity Small cell lung cancer recurrent Myelofibrosis Cutaneous T-cell lymphoma Adenocarcinoma gastric Hypomagnesaemia More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid – Life with Disease Basal cell naevus syndrome – Trials in Disease Combined immunodeficiency Rosai-Dorfman syndrome – Trials in Disease Alport’s syndrome – Treatment Ewing’s sarcoma – Life with Disease Ewing’s sarcoma recurrent Cerebral arteriovenous malformation haemorrhagic – Basic Information Indolent systemic mastocytosis – Life with Disease Cystic fibrosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Imetelstat Sodium Dazostinag Golodirsen Calcium Chloride Posenacaftor Utreglutide GSKVX000000040033 Bemnifosbuvir Hemisulfate Mbf-015 Aluminium Hydroxide ACARBOSE Vx-264 Tafasitamab Iptacopan Ivabradine Hydrochloride Elexacaftor Nystatin AGANIRSEN Teprotumumab Macrogol 3350 More therapies…

    Learn about Your Condition

    Hydrocephalus Behcet's syndrome Haemodynamic instability Primary hyperthyroidism Plasma cell myeloma recurrent Narcolepsy Cryoglobulinaemia Genitourinary tract neoplasm Embolic stroke Peripheral artery restenosis Hepatotoxicity Diabetes insipidus Large cell lung cancer stage 0 Cold type haemolytic anaemia Oedema peripheral More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Radiotherapy and Antiandrogens for Patients with Advanced Prostate Cancer Using Abiraterone Acetate and Enzalutamide

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Enzalutamide
    Spain

  • Study on the Effectiveness of Belumosudil and Azithromycin for Adults with Chronic Lung Rejection After Lung Transplant

    Recruiting

    3 1 1
    Investigated Drugs:
    • Anhydrous Azithromycin
    • Belumosudil Mesilate
    Austria Belgium Czechia Denmark Finland France +8

  • Study on the Effects and Safety of Inebilizumab for Patients with Anti-NMDA Receptor Encephalitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Encephalitis autoimmune
    Investigated Drugs:
    • Cetirizine
    • Human Normal Immunoglobulin (Iv)
    • Inebilizumab
    The Netherlands Spain

  • Study on the Effects of Metreleptin for Patients with Partial Lipodystrophy

    Recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Partial lipodystrophy
    Investigated Drugs:
    • Metreleptin
    France Germany Italy

  • Study on Aconite Pain Oil to Prevent and Reduce Symptoms of Chemotherapy-Induced Polyneuropathy in Cancer Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Polyneuropathy
    Investigated Drugs:
    • D-Camphor
    • Lavender Oil
    • Taxanes
    Germany

  • Study on Sodium Thiosulfate to Prevent Hearing Loss in Patients with Head and Neck Cancer Receiving Cisplatin Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Sodium Thiosulfate
    The Netherlands
Previous Page
1 … 538 539 540 541 542 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!